First clinical scan using XENOVIEW™ conducted at Cincinnati Children’s Hospital Medical Center Posted on May 11, 2023 by Brady Anna
Polarean to be a featured company at 2023 ATS Respiratory Innovation Summit Posted on May 3, 2023 by Brady Anna
FDA Grants New Chemical Entity designation for XENOVIEW™ (xenon Xe 129 hyperpolarized) Posted on February 14, 2023February 16, 2023 by Brady Anna
FDA Approves Polarean’s XENOVIEW™ (xenon Xe 129 hyperpolarized) Posted on December 28, 2022January 26, 2023 by Brady Anna
Complete Response Letter Received from FDA Posted on October 6, 2021January 26, 2023 by Amanda Monroe
